← Product Code [JLA](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JLA) · K852767

# ERYTHOCYTE CREATINE (K852767)

_Panmed, Inc. · JLA · Nov 13, 1986 · Clinical Chemistry · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/HE/subpart-b%E2%80%94clinical-chemistry-test-systems/JLA/K852767

## Device Facts

- **Applicant:** Panmed, Inc.
- **Product Code:** [JLA](/submissions/CH/subpart-b%E2%80%94clinical-chemistry-test-systems/JLA.md)
- **Decision Date:** Nov 13, 1986
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 862.1210
- **Device Class:** Class 1
- **Review Panel:** Clinical Chemistry

## Regulatory Identification

A creatine test system is a device intended to measure creatine (a substance synthesized in the liver and pancreas and found in biological fluids) in plasma, serum, and urine. Measurements of creatine are used in the diagnosis and treatment of muscle diseases and endocrine disorders including hyperthyroidism.

---

**Source:** [https://fda.innolitics.com/submissions/HE/subpart-b%E2%80%94clinical-chemistry-test-systems/JLA/K852767](https://fda.innolitics.com/submissions/HE/subpart-b%E2%80%94clinical-chemistry-test-systems/JLA/K852767)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com
